Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation

American Heart Journal

Volumn 158, Issue 1, 2009, Pages 92-98

  Ota, Tomoyuki ^a   Umeda, Hisashi ^a   Yokota, Shigeki ^a   Miyata, Shinjiro ^a   Takamura, Atsushi ^a   Sugino, Shigeo ^a   Hayashi, Kazutaka ^a   Ishiki, Ryoji ^a   Takeichi, Yasushi ^a   Iwase, Mitsunori ^a   Inagaki, Haruo ^a   Murohara, Toyoaki ^b  

^a TOYOTA MEMORIAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESTENOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CAUSE OF DEATH; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; EQUIPMENT FAILURE ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK FACTORS; SIROLIMUS;

EID: 67049161977     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.04.013     Document Type: Article

References (30)

1. Imai E., Horio M., Iseki K., et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 11 (2007) 188-189
2. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
3. Keith D.S., Nichols G.A., Gullion C.M., et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
4. McCullough P.A. Coronary artery disease. Clin J Am Soc Nephrol 2 (2007) 611-616
5. Azar R.R., Prpic R., Ho K.K., et al. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 86 (2000) 485-489
6. Rubenstein M.H., Harrell L.C., Sheynberg B.V., et al. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?. Circulation 102 (2000) 2966-2972
7. Le Feuvre C., Dambrin G., Helft G., et al. Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting. Heart 85 (2001) 556-560
8. Best P.J., Berger P.B., Davis B.R., et al. PRESTO Investigators. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. J Am Coll Cardiol 44 (2004) 1786-1791
9. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
10. Marroquin O.C., Selzer F., Mulukutla S.R., et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 358 (2008) 342-352
11. Lemos P.A., Arampatzis C.A., Hoye A., et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 95 (2005) 167-172
12. Kuchulakanti P.K., Torguson R., Chu W.W., et al. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol 97 (2006) 792-797
13. Ishio N., Kobayashi Y., Takebayashi H., et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 71 (2007) 1525-1529
14. Aoyama T., Ishii H., and Toriyama T. Sirolimus-eluting stents vs. bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 72 (2008) 56-60
15. Imai E., Horio M., Nitta K., et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 11 (2007) 41-50
16. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
17. Notohamiprodjo M., Andrassy K., Bommer J., et al. Dialysis membranes and coagulation system. Blood Purif 4 (1986) 130-141
18. Jungers P., Massy Z.A., Nguyen Khoa T., et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 12 (1997) 2597-2602
19. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
20. Tamashiro M., Iseki K., Sunagawa O., et al. Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38 (2001) 64-69
21. Zahn R., Hamm C.W., Schneider S., et al. German Cypher Stent Registry. Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry. Am Heart J 152 (2006) 1146-1152
22. Mishkel G.J., Varghese J.J., Moore A.L., et al. Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease. J Invasive Cardiol 19 (2007) 331-337
23. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
24. Nakazawa G., Tanabe K., Aoki J., et al. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Cathet Cardiovasc Interv 69 (2007) 808-814
25. Fujii K., Mintz G.S., Kobayashi Y., et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 109 (2004) 1085-1088
26. Kuriyama N., Kobayashi Y., Nakayama T., Kuroda N., and Komuro I. Damage to polymer of a sirolimus-eluting stent. Circulation 114 (2006) e586-e587
27. Cook S., Wenaweser P., Togni M., et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115 (2007) 2426-2434
28. Tsutsui M., Shimokawa H., Tanaka S., et al. Granulocyte activation in restenosis after percutaneous transluminal coronary angioplasty. Jpn Circ J 60 (1996) 27-34
29. Aronson D. Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure. Med Hypotheses 59 (2002) 297-301
30. Nishimura M., Hashimoto T., Kobayashi H., et al. Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients. Nephrol Dial Transplant 21 (2006) 1640-1647